Research antianemic action of the iron (IV) clathrochelate complexes on the sickling piglets
A lot of antianemic drugs for animals are presented on the modern pharmaceutical market of veterinary medicine, but they have several drawbacks. So finding new drugs with goal to treat ill animals by anemia and to prevent the iron deficiency anemia is a pressing issue. We previously reported the results of preclinical studies of iron in rare high valence IV. This allowed us to determine, supplement, and generalize the data on clinical studies of the new drugs with the active substance iron (IV) clathrochelate. Therefore, the article presents the results of studies of its antianemic effect on sickling piglets. Experiments were carried out on piglets-analogues neonates, which were divided into three groups: control and two experimental groups. Piglets were kept with sows on suckling. For the purpose of prevention iron deficiency anemia the traditional solution of iron dextran was administered once intramuscularly to piglets of I control group. The aqueous solution of iron (IV) clathrochelate complexes was administered once intramuscularly to piglets of II experimental group. Iron (IV) clathrochelate complexes was dissolved in a solvent of rheopolyglucin and administered once intramuscularly to piglets of III experimental group. 1 mL of test solutions contained 100 mg of active substance. The investigative material were the samples of blood and serum of piglets, their liver and spleen. The experiment lasted during a 30-day period since birth of piglets. According to the results of the experiments, iron (IV) clatrochelate complexes which was dissolved in a water for injection and rheopolyglucin had higher antianemic activity compared to the control. This is evidenced by the dynamics of probable changes in the number of erythrocytes, hemoglobin content and hematocrit, Iron content in serum and its mass fraction in the blood, liver and spleen of piglets. The effectiveness of the action of iron (IV) clatrochelate complexes is explained by the full supply of piglets with iron and its higher bioavailability..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Науковий вісник Львівського національного університету ветеринарної медицини та біотехнологій імені С.З. Ґжицького: Серія Ветеринарні науки - 22(2020), 99, Seite 107-115 |
| Sprache: |
Englisch ; Russisch ; Ukrainisch |
|---|
| Beteiligte Personen: |
V. B. Dukhnitskyi [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Iron deficiency anemia, clinical studies, iron (iv), piglets, morphological parameters, biochemical indica-tors |
|---|
| doi: |
10.32718/nvlvet9917 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ023322497 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ023322497 | ||
| 003 | DE-627 | ||
| 005 | 20230503055157.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.32718/nvlvet9917 |2 doi | |
| 035 | |a (DE-627)DOAJ023322497 | ||
| 035 | |a (DE-599)DOAJ2c5206a397cc4fba8cfffbd46984eef6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a rus |a ukr | ||
| 050 | 0 | |a SF600-1100 | |
| 100 | 0 | |a V. B. Dukhnitskyi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Research antianemic action of the iron (IV) clathrochelate complexes on the sickling piglets |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a A lot of antianemic drugs for animals are presented on the modern pharmaceutical market of veterinary medicine, but they have several drawbacks. So finding new drugs with goal to treat ill animals by anemia and to prevent the iron deficiency anemia is a pressing issue. We previously reported the results of preclinical studies of iron in rare high valence IV. This allowed us to determine, supplement, and generalize the data on clinical studies of the new drugs with the active substance iron (IV) clathrochelate. Therefore, the article presents the results of studies of its antianemic effect on sickling piglets. Experiments were carried out on piglets-analogues neonates, which were divided into three groups: control and two experimental groups. Piglets were kept with sows on suckling. For the purpose of prevention iron deficiency anemia the traditional solution of iron dextran was administered once intramuscularly to piglets of I control group. The aqueous solution of iron (IV) clathrochelate complexes was administered once intramuscularly to piglets of II experimental group. Iron (IV) clathrochelate complexes was dissolved in a solvent of rheopolyglucin and administered once intramuscularly to piglets of III experimental group. 1 mL of test solutions contained 100 mg of active substance. The investigative material were the samples of blood and serum of piglets, their liver and spleen. The experiment lasted during a 30-day period since birth of piglets. According to the results of the experiments, iron (IV) clatrochelate complexes which was dissolved in a water for injection and rheopolyglucin had higher antianemic activity compared to the control. This is evidenced by the dynamics of probable changes in the number of erythrocytes, hemoglobin content and hematocrit, Iron content in serum and its mass fraction in the blood, liver and spleen of piglets. The effectiveness of the action of iron (IV) clatrochelate complexes is explained by the full supply of piglets with iron and its higher bioavailability. | ||
| 650 | 4 | |a iron deficiency anemia, clinical studies, iron (iv), piglets, morphological parameters, biochemical indica-tors | |
| 653 | 0 | |a Veterinary medicine | |
| 700 | 0 | |a I. M. Derkach |e verfasserin |4 aut | |
| 700 | 0 | |a S. S. Derkach |e verfasserin |4 aut | |
| 700 | 0 | |a I. O. Fritsky |e verfasserin |4 aut | |
| 700 | 0 | |a M. O. Plutenko |e verfasserin |4 aut | |
| 700 | 0 | |a V. M. Lozovyi |e verfasserin |4 aut | |
| 700 | 0 | |a V. V. Kostrub |e verfasserin |4 aut | |
| 700 | 0 | |a Y. V. Losa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Науковий вісник Львівського національного університету ветеринарної медицини та біотехнологій імені С.З. Ґжицького: Серія Ветеринарні науки |d Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologies Lviv, 2020 |g 22(2020), 99, Seite 107-115 |w (DE-627)DOAJ000048496 |x 25181327 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2020 |g number:99 |g pages:107-115 |
| 856 | 4 | 0 | |u https://doi.org/10.32718/nvlvet9917 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/2c5206a397cc4fba8cfffbd46984eef6 |z kostenfrei |
| 856 | 4 | 0 | |u https://nvlvet.com.ua/index.php/journal/article/view/4014 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2518-7554 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2518-1327 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2020 |e 99 |h 107-115 | ||